Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

How to access Pharma in Focus articles
  • If you're a current subscriber, See below

  • If you're new to Pharma in Focus, Click here

  • If you haven't SUBSCRIBED yet, Click here

Current Subscribers

If you are are current Full Text Subscriber or have taken out a Free Trial, please type your email address into the form below.

This will restore your access and return you to the Home Page.

Email Address
 
Pipeline Monitor
Janssen's Humira-topping med approved
After a shortened review process, Janssen's new, first-up IL-23 blocker has been approved for severe plaque psoriasis in the US.
Perspective
PBS clawback heads for day in court
The Commonwealth's attempt to claw back PBS cash from Sanofi that it says should never have been paid is due in court again next month but, big money aside, what's the point now?
Approvals Action
Roche's star MS drug approved
Roche has won approval for a new first-in-class multiple sclerosis drug just a week after the PBAC considered it for reimbursement.